HEALTHCARE

IBTimes Logo

U.S. jobless rate hits 26-year high of 9.8 percent

U.S. employers unexpectedly cut more jobs in September than in August, underscoring the fragility of the economy's recovery from its worst recession in 70 years as businesses remain cautious about the future.

Big pharma jumps back into flu business

IBTimes Logo
A dearth of new products, new technologies and fresh commitments by governments scrambling to protect their populations from pandemic threats have lured U.S. drugmakers back into the flu vaccine business.
More news
IBTimes Logo

Canada outranks U.S. in healthcare report card

Canada outperforms the United States in health outcomes but is well behind global leaders like Japan in overall health of its population, a Canadian report released on Monday showed.
IBTimes Logo

Abbott, J&J strike deals, boost vaccines

The world's two largest diversified healthcare companies struck deals on Monday that will propel them into vaccines, a red-hot area for investors because of the pandemic flu threat and potential high profits for preventing other diseases.
IBTimes Logo

Abbott, J&J to bulk up in Europe, vaccines

U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday, aimed at securing vaccines and other products key to future growth.
IBTimes Logo

Heavy lifting ahead for Obama on diplomatic agenda

After his efforts at diplomacy on the international stage last week, President Barack Obama faces some particularly daunting foreign policy decisions about the Afghan war, a nuclear Iran and an elusive Middle East peace.
IBTimes Logo

Johnson & Johnson buys 18 pct stake in Crucell

U.S. diversified health care company Johnson & Johnson has bought an 18 percent stake in biotech firm Crucell for 302 million euros ($444 million) as part of a flu vaccine development deal, the Dutch company said on Monday.
IBTimes Logo

Abbott, Johnson & Johnson bulk up in Europe

U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday aimed at securing vaccines and other products key to future growth.
IBTimes Logo

Abbott to buy Solvay unit for $6.6 billion: sources

U.S. drugmaker Abbott Laboratories plans to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros), two sources familiar with the situation said on Sunday, with an announcement expected on Monday.
IBTimes Logo

Abbott to buy Solvay unit for $6.6 bln: sources

U.S. drugmaker Abbott Laboratories plans to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros), two sources familiar with the situation said on Sunday, with an announcement expected on Monday.
IBTimes Logo

Abbott to buy Solvay unit for $6.6 billion: source

U.S. drugmaker Abbott Laboratories is planning to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros) in cash, with an announcement expected in the next 24 hours, a source familiar with the situation said on Sunday.
IBTimes Logo

Massachusetts names Kirk to fill Kennedy Senate seat

Paul Kirk, a former Democratic National Committee chairman and a close friend of the late Senator Edward Kennedy, was named on Thursday as a temporary replacement for the liberal champion in the U.S. Senate.
IBTimes Logo

U.S. Senate panel rejects Republican healthcare moves

The Senate Finance Committee battled over insurance plans for seniors on Wednesday and rejected a Republican effort to delay a final vote on a broad healthcare overhaul as it slowly waded through a crush of amendments.
IBTimes Logo

Senate panel debates healthcare affordability

Democrats pushed on Tuesday to make insurance reforms more affordable for workers and Republicans decried what they called a rush to judgment, as a key Senate panel began debate on a sweeping healthcare overhaul.
IBTimes Logo

Obama star power faces new test at U.N meeting

U.S. President Barack Obama makes his United Nations debut on Wednesday, hoping his international star power can throw new muscle behind a policy agenda that is already struggling to deliver.
IBTimes Logo

White House targets insurers over healthcare premiums

The White House kept insurance companies squarely in its sights on Tuesday in the push for healthcare reform by releasing research showing that health insurance premiums have risen far faster than inflation in every U.S. state.
IBTimes Logo

Obama: healthcare won't hike middle class taxes

President Barack Obama insisted he can overhaul the U.S. healthcare system without raising taxes for anyone but the wealthiest Americans, in a media barrage on Sunday as he sought to take control of the debate on his top domestic policy priority.
IBTimes Logo

Dell to buy Perot Systems for $3.9 billion

Dell Inc plans to buy Perot Systems Corp for about $3.9 billion, paying a steep 67.5 percent premium to expand its technology services business and compete with Hewlett-Packard Co and IBM.
IBTimes Logo

Obama pushes economic message ahead of big summits

President Barack Obama's multitasking abilities will be tested this week as he juggles war, diplomacy and finance on a high-profile world stage along with the American public's top concern: the U.S. economy.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.